The South African Health Products Regulatory Authority says there are no major safety concerns with the Johnson and Johnson vaccine.
It has studied the data from the Sisonke trial and found no reports of blood clots.
The body is now recommending lifting the suspension on the Sisonke study but says there should be better screening and monitoring of participants at high risk of blood clotting disorders.
The regulator also says all participants should be informed about the risk of developing the disorder.
South Africa suspended the trial after US Federal Health Agencies recommended the pause.
Six women there developed a blood clotting disorder after receiving the Johnson & Johnson vaccine.
More Stories
KZN Premier Dube-Ncube Reshuffles Cabinet
Ace Magashule’s Appeal Dismissed by the Constitutional Court
Delays in Zandile Gumede Corruption Case Enrages Judge
Ramaphosa Should Apologise Says Widows of Miners in Marikana
Zikalala Reinstated to the Executive in the KZN Legislature
The 3 Biggest Problems With Remote Work – What The Research Says
Are Old School Methods Of Saving Holding South Africans Back?
Affected Families Of Marikana Massacre To Get Update On Compensation
Suspects Arrested In Krugersdorp Due Back In Court
Western Cape DA Calls On Ramaphosa To Fire Cele
Malema Slams Zondo Appointment As Chief Justice
Struggle For Women Not Yet Over – Ramaphosa